Latest filing published 17 Feb 2022 for Protagonist Therapeutics, Inc.
Insider track record
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Donald A. Kalkofen: trading record in brief
Donald A. Kalkofen is a declared insider of Protagonist Therapeutics, Inc (finance chief), with filings sourced from SEC (Form 4). Between 3 December 2019 and 15 February 2022, the trades on record add up to 4 filings.
Every open-market trade on record is a purchase: 2 purchases worth €5,404, and no sale. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Besides market trades, the filings include 2 share grants.
The record was last updated on 17 February 2022 with a share grant in Protagonist Therapeutics, Inc. The last purchase on record was published on 3 December 2019, which is 2,533 days ago. The median gap between trade and publication is zero days: most filings appear on the same day. US insiders must file a Form 4 within two business days of a trade. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Donald A. Kalkofen
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 7,500 shares0Common StockSEC:0001104659-22-024841:0
1 of 1 declaration
